» Articles » PMID: 35784911

Metabolic Syndrome (MetS), Systemic Inflammatory Response Syndrome (SIRS), and Frailty: Is There Any Room for Good Outcome in the Elderly Undergoing Emergency Surgery?

Overview
Journal Front Surg
Specialty General Surgery
Date 2022 Jul 5
PMID 35784911
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with MetS or SIRS experience higher rates of mortality and morbidity, across both cardiac and noncardiac surgery. Frailty assessment has acquired increasing importance in recent years as it predisposes elderly patients to a worse outcome. The aim of our study was to investigate the influence of MetS, SIRS, and with or without frailty on elderly patients undergoing emergency surgical procedures.

Methods: We analyzed data of all patients with nonmalignant diseases requiring an emergency surgical procedure from January 2017 to December 2020. The occurrence of MetS was identified using modified definition criteria used by the NCEP-ATP III Expert Panel: obesity, hypertension, diabetes, or if medication for high triglycerides or for low HDL cholesterol was taken. Systemic inflammatory response syndrome (SIRS) was evaluated according to the original consensus study (Sepsis-1). The frailty profile was investigated by the 5-modified Frailty Index (5-mFI) and the Emergency Surgery Frailty Index (EmSFI). Postoperative complications have been reported and categorized according to the Clavien-Dindo (C-D) classification system. Morbidity and mortality have been mainly considered as the 30-day standard period definition.

Results: Of the 2,318 patients included in this study, 1,010 (43.6%) fulfilled the criteria for MetS (MetsG group). Both 5-Items score and EmsFI showed greater fragility in patients with MetS. All patients with MetS showed more frequently a CACI index greater than 6. The occurrence of SIRS was higher in MetSG. LOS was longer in patients with MetS (MetSG 11.4 ± 12 days vs. -MetSG 10.5 ± 10.2 days,  = 0.046). MetSG has a significantly higher rate of morbidity (353 (35.%) vs. 385 (29.4%),  = 0.005). The mortality rate in patients with MetS (98/1010, 10%) was similar to that in patients without it (129/1308, 10%). Considering patients with MetS who developed SIRS and those who had frailty or both, the occurrence of these conditions was associated with a higher rate of morbidity and mortality.

Conclusion: Impact of MetS and SIRS on elderly surgical patient outcomes has yet to be fully elucidated. The present study showed a 43.6% incidence of MetS in the elderly population. In conclusion, age per se should be not considered anymore as the main variable to estimate patient outcomes, while MetS and Frailty should have always a pivotal role.

Citing Articles

Clinical Impact of Sarcopenia in the Decision-Making Process for Patients with Acute Diverticulitis.

Puccioni C, Fransvea P, Rodolfino E, Cintoni M, Vacca A, Benedetto D J Clin Med. 2025; 14(1.

PMID: 39797093 PMC: 11721328. DOI: 10.3390/jcm14010007.


Heme-Inducing Endothelial Pyroptosis Plays a Key Role in Radiofrequency Ablation of Hepatic Hemangioma Leading to Systemic Inflammatory Response Syndrome.

Yao C, Kong J, Xu F, Wang S, Wu S, Sun W J Inflamm Res. 2024; 17:371-385.

PMID: 38260812 PMC: 10802182. DOI: 10.2147/JIR.S435486.


The Emergency Surgery Frailty Index (EmSFI) in Elderly Patients with Acute Appendicitis: An External Validation of Prognostic Score.

Fusario D, Neri A, Carbone L, Resca L, Marano L, Gassi G World J Surg. 2023; 47(7):1713-1720.

PMID: 36947203 PMC: 10229705. DOI: 10.1007/s00268-023-06975-w.


Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.

Marti-Chillon G, Muntion S, Preciado S, Osugui L, Navarro-Bailon A, Gonzalez-Robledo J Clin Transl Med. 2023; 13(1):e1163.

PMID: 36588089 PMC: 9806020. DOI: 10.1002/ctm2.1163.


The Best Way to Deal Is with Cold Steel…Is It?-Ways of Dealing with Age and Ageing in Cardiac Surgery.

Albes J J Clin Med. 2022; 11(23).

PMID: 36498689 PMC: 9738380. DOI: 10.3390/jcm11237116.


References
1.
Cornier M, Dabelea D, Hernandez T, Lindstrom R, Steig A, Stob N . The metabolic syndrome. Endocr Rev. 2008; 29(7):777-822. PMC: 5393149. DOI: 10.1210/er.2008-0024. View

2.
Zhang X, Lerman L . The metabolic syndrome and chronic kidney disease. Transl Res. 2016; 183:14-25. PMC: 5393937. DOI: 10.1016/j.trsl.2016.12.004. View

3.
Bhayani N, Hyder O, Frederick W, Schulick R, Wolgang C, Hirose K . Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012; 152(2):218-26. PMC: 3648869. DOI: 10.1016/j.surg.2012.05.037. View

4.
Dent E, Kowal P, Hoogendijk E . Frailty measurement in research and clinical practice: A review. Eur J Intern Med. 2016; 31:3-10. DOI: 10.1016/j.ejim.2016.03.007. View

5.
Glance L, Wissler R, Mukamel D, Li Y, Diachun C, Salloum R . Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology. 2010; 113(4):859-72. DOI: 10.1097/ALN.0b013e3181eff32e. View